Marcia S. Graudenz
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer.
Journal: Breast cancer research : BCR
Published: January 03, 2026
Diagnostic performance of ACR-TIRADS for thyroid nodule risk stratification in pediatric patients.
Journal: Endocrine
Published: May 14, 2025
Unlocking breast cancer in Brazilian public health system: Using tissue microarray for accurate immunohistochemical evaluation with limitations in subtyping.
Journal: Women's health (London, England)
Published: January 02, 2025
Comparison of cephalometric results obtained with orthodontic camouflage using Roth and Biofuncional brackets and orthognathic surgery.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: May 03, 2024
Trop-2 Is Highly Expressed in Early Luminal-Like Breast Cancer.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: September 07, 2023
Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: August 07, 2023
Age-related variation in malignant cytology rates of thyroid nodules: insights from a retrospective observational study assessing the ACR TI-RADS.
Journal: European journal of endocrinology
Published: July 11, 2023
Active Surveillance of Differentiated Thyroid Cancer Metastatic Cervical Lymph Nodes: A Retrospective Single-Center Cohort Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 21, 2023
Using an ultrasonography risk stratification system to enhance the thyroid fine needle aspiration performance.
Journal: European journal of radiology
Published: July 23, 2021
ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy.
Journal: Frontiers in oncology
Published: December 10, 2019
Last Updated: 09/26/2026